This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The FDA approved nitisinone (Harliku) for the reduction of urine homogentisic acid (HGA) in patients with alkaptonuria (AKU). The FDA approved nitisinone (Harliku) for the reduction of urine homogentisic acid (HGA) in patients with alkaptonuria (AKU). The medication is expected to launch in July 2025.
The FDA approved insulin aspart-xjhz (Kirsty) 100 units/mL as the first and only interchangeable biosimilar to insulin aspart (NovoLog). 1 The FDA approves Kirsty, an interchangeable biosimilar insulin, enhancing diabetes treatment options and accessibility for patients.
She highlighted the challenges of maintaining accurate, transparent vaccine guidance, focusing on the importance of trusted health care providers helping patients understand immunization strategies.
In 2022, the Advisory Committee on Immunization Practices (ACIP) published updated pneumococcal vaccine recommendations. Increasing pneumococcal vaccine uptake is especially important in light of the recent COVID-19 pandemic that disrupted routine immunization services and highlighted the vulnerability of adults to respiratory infections.”
The FDA approved telmisartan, amlodipine and indapamide (Widaplik) for the treatment of hypertension in adult patients, George Medicines said in a release. The FDA approved telmisartan, amlodipine and indapamide (Widaplik) for the treatment of hypertension in adult patients, George Medicines said in a release.
Recent Videos Related Content Q&A: Current Advancements in Insulin Delivery for Patients with Diabetes Brian Nowosielski ; Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES July 11th 2025 Article Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, joins Drug Topics to discuss her extensive background in managing patients’ insulin regimens.
Recent Videos Related Content FDA to Evaluate Merck’s Doravirine, Islatravir Regimen for HIV-1 Killian Meara July 10th 2025 Article The FDA set a Prescription Drug User Fee Act (PDUFA) date of April 28, 2026. Subscribe Now!
Knockel: I'm encouraging patients to talk to trusted health care professionals and to not get their advice from social media or the internet or other strangers, focusing on the fact that vaccines have been studied before, during, and after FDA approval.
1 "Lilly was the first company to offer a self-pay solution for an FDA-approved obesity medication, and we continue to work to expand coverage for Zepbound. mg and 15 mg vials of tirzepatide starting July 7, with shipments beginning in early August. Eli Lilly announced that the highest doses of tirzepatide (Zepbound)—12.5
Recent Videos Related Content Flip The Pharmacy April Schedule & Sign-Up March 28th 2024 Article Check out these can't-miss Workflow Wednesdays sessions in April. Flip The Pharmacy March Schedule & Sign-Ups March 4th 2024 Article Check out these can't-miss Workflow Wednesdays sessions in March.
link] Recent Videos Related Content CDC Report Finds No Connection Between Thimerosal and Autism Ashley Gallagher June 25th 2025 Article Thimerosal is a mercury-containing compound that has been widely used as a preservative in some biological and drug products since the 1930s. Drug Topics. March 25, 2025. Accessed June 30, 2025.
Recent Videos Related Content Q&A: How Advancements in GLP-1s, CGM Impact Insulin Management Brian Nowosielski ; Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES July 15th 2025 Article Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discusses how diabetes advancements like GLP-1s and CGM have impacted the management of insulin.
Garofoli, PharmD, BCACP, CTTS, FAPhA Publication Article Drug Topics Journal Drug Topics May/June 2025 Volume 169 Issue 03 Pharmacy team members can help patients prepare for upcoming travels, ensuring they are up to date with the recommended vaccines for their locations. The first resource is the CDC’s Yellow Book.
Q&A: PBM Unbundling, New Pricing Models Create More Transparency Brian Nowosielski ; Morgan Lee, PhD, MPH, CPH ; Scott Halperin, PharmD June 24th 2025 Article Morgan Lee, PhD, MPH, CPH, and Scott Halperin, PharmD, from the Pharmaceutical Strategies Group, discuss how the role of PBMs in plan design is evolving.
From fast-acting and long-acting insulins to those requiring a meal, the standards of care for insulin delivery have changed over the years as researchers aim to develop insulin that best regulates the blood glucose of patients with diabetes.
3,4 Since then, several other formulations have received FDA approval, leading to research developments of multiple GLP-1s for treating people with overweight or obesity. image credit: photoopus / stock.adobe.com The first GLP-1RA approved for use in the US was exenatide (Byetta) in 2005 for patients with type 2 diabetes (T2D).
Experts discuss the recent dismissal of all 17 members of the Advisory Committee on Immunization Practices (ACIP), a panel that provides guidance to the CDC on vaccine recommendations. This abrupt change has raised significant concerns within the health care community about the potential impact on vaccine trust and public health policy.
The sessions this year range from business sessions, including topics on product placement, advocacy, and inventory management, to educational sessions, including diabetes, immunizations, and hormonal contraceptive services. The Drug Topics team will be onsite at the meeting providing coverage of all the most important happenings.
Researchers then summarized each article included in the review and presented the notable themes of each. A collaborative and patient-centered approach is crucial in improving polypharmacy outcomes, according to a study published in Intelligent Hospital. Those terms included: patient, health, polypharmacy, ramification, and utilization.
Recent Videos Related Content Senators Reintroduce Bill to Improve Pharmacist Medicare Reimbursement Brian Nowosielski July 25th 2025 Article Senators Warner and Thune reintroduced the ECAPS legislation improving both seniors’ access to care and pharmacists’ ability to get reimbursed for clinical services. Subscribe Now!
National Vice President, RxOwnership July 10th 2025 Article Independent pharmacists must not only prioritize patient care, but also financial stewardship, to maintain a confident business outlook amid industry headwinds.
Recent Videos Related Content Q&A: How Iowa PBM Bill is Set to Preserve Pharmacy Access Brian Nowosielski ; Brett Barker, PharmD July 8th 2025 Article Brett Barker, PharmD, State Representative in Iowa’s 51st District, joined Drug Topics to discuss significant implications and common misconceptions regarding Iowa’s new PBM bill.
Additionally, pharmacists can make sure that patients have updated immunizations, especially for patients who are on immunosuppressive therapy. TikTok and other social media have the potential to reach younger adults, who have a peak age of onset for inflammatory bowel disease (IBD) between 15 and 29 years.
link] Recent Videos Related Content Eli Lilly Adds Highest Doses of Zepbound to Online Pharmacy Platform Ashley Gallagher June 16th 2025 Article Providers can prescribe the 12.5 1 The program will include branded obesity glucagon-like peptide-1 medications, which will have a transparent monthly cost. May 10, 2024. June 18, 2025.
Recent Videos Related Content GLP-1s Effective as Adjunctive Therapy in Patients with T1D, Obesity | ADA 2025 Brian Nowosielski July 2nd 2025 Article Researchers explored patients with type 1 diabetes and overweight or obesity to understand the efficacy and safety of GLP-1s as adjunctive therapies.
Recent Videos Related Content Collaborative, Pharmacist-Led Approach Crucial in Polypharmacy Brian Nowosielski July 18th 2025 Article Emphasizing the pharmacist’s essential role, researchers explored the causes, consequences, and clinical implications of polypharmacy. Subscribe Now!
Recent Videos Related Content Q&A: Pharmacists Play Essential Role in Insulin Therapy Success Killian Meara ; Jennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM July 15th 2025 Article Jennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM, discusses how pharmacists can help patients manage insulin.
Recent Videos Related Content Q&A: Pharmacies Grapple With Patient Influx Amid Rite Aid Closures Killian Meara ; Rob Frankil, RPh July 1st 2025 Article Rob Frankil, RPh, discusses how independent pharmacies in Pennsylvania are dealing with the impact of Rite Aid stores closing.
Similar to Phillips’ idea of planning ahead, the FDA also has detailed provisions for patients to take during power outages, floods, or other events that compromise their ability to manage their medications. “An An emergency plan is especially important for those with health concerns, particularly if the power goes out.
Recent Videos Related Content Q&A: Pharmacy Desert Improvement Reliant on Industry Advocacy, Reform Brian Nowosielski ; Michael Murphy, PharmD, MBA July 23rd 2025 Article Michael Murphy, PharmD, MBA, provided insights on his research regarding pharmacy deserts, who they impact the most, and the methods needed to improve them in the US.
Recognition matters—whether it’s posting their certifications, assigning leadership roles like inventory or immunization coordination, or simply trusting them with responsibilities they already handle. Pharmacists can also advocate for them by acknowledging unfair pay or treatment and being transparent about efforts to improve conditions.
Q&A: How Advancements in GLP-1s, CGM Impact Insulin Management Brian Nowosielski ; Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES July 15th 2025 Article Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discusses how diabetes advancements like GLP-1s and CGM have impacted the management of insulin.
Recent Videos Related Content Diabetes Risk Reduction Practices Low for Women With Gestational Diabetes Ashley Gallagher June 13th 2025 Article For women in rural populations, access to education and care is limited, causing disparities in diabetes care. 1 Authors of the study said more research is needed to confirm the results.
Recent Videos Related Content Q&A: Current Advancements in Insulin Delivery for Patients with Diabetes Brian Nowosielski ; Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES July 11th 2025 Article Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, joins Drug Topics to discuss her extensive background in managing patients’ insulin regimens.
Recent Videos Related Content Collaborative, Pharmacist-Led Approach Crucial in Polypharmacy Brian Nowosielski July 18th 2025 Article Emphasizing the pharmacist’s essential role, researchers explored the causes, consequences, and clinical implications of polypharmacy. Subscribe Now!
link] Recent Videos Related Content Significant Knowledge Gap Exists in Patient Awareness of Psoriatic Disease Brian Nowosielski June 11th 2025 Article Using the “Psoriasis and Beyond” survey design, researchers addressed patients’ awareness of psoriatic diseases and their associated comorbidities.
With a specific focus on preconception care, Natalie and David discuss opportunities for management of medications associated with adverse pregnancy outcomes, immunizations, OTC medications, and hormonal contraception, as well as strategies for phrasing recommendations during conversation with patients.
Currently it’s going to be slowing to upper single digits through the forecast period, basically because 2 of the leading drugs, there's immune checkpoint inhibitors—nivolumab is the molecule—and pembrolizumab is Keytruda, 2 of those are going off patent in 2028 and 2029. That trend is in the low-to-mid teens in terms of growth rate.
Recent Videos Related Content Insulin Advancements Led to Safer Surgeries, Shorter Hospital Stays Brian Nowosielski July 11th 2025 Article Researchers conducted a narrative review of the insulins available for diabetes management and which pharmacological options are best in the perioperative period and within clinical care. Subscribe Now!
Q&A: Support, Reimbursement Key For Expanded Pharmacy Services | PQA 2025 Killian Meara ; Michael Hegener, PharmD, BCACP May 29th 2025 Article Michael Hegener, PharmD, BCACP, discusses how workforce development can best address the evolving knowledge, skills, and abilities needed in community pharmacy practice.
link] Recent Videos Related Content Pharmacist Outreach Reduces Therapeutic Inertia in T2D | ADA 2025 Killian Meara June 23rd 2025 Article Data presented at ADA’s 85th Scientific Sessions showed patients who received physician education with clinical pharmacist outreach had significantly better A1c levels at 6 months compared to usual care.
Recent Videos Related Content Q&A: Pharmacy Teams Leverage Technology and Collaboration to Optimize Inventory | McKesson ideaShare Ashley Gallagher ; Thomas Sherrer, PharmD July 17th 2025 Article Thomas Sherrer, PharmD, emphasizes teamwork and technology in inventory management to enhance patient safety and reduce medication errors.
link] Recent Videos Related Content Importance of Skin-Gut Axis Communication in Homeostasis Brian Nowosielski June 18th 2025 Article The review explored the “emerging” term gut-skin axis and aimed to decipher the bidirectional signaling of the skin and gastrointestinal tract during homeostatic and disease states.
Recent Videos Related Content Register Today: June 2025 Total Pharmacy Solutions Summit Brian Nowosielski June 2nd 2025 Article The event will focus on revenue stream diversification, providing independent pharmacies with seeds of innovation and practical tools to cultivate new avenues for growth in pharmacy.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content